Augustinus Bader secures unicorn status with latest funding
Multi-award-winning skincare and haircare brand Augustinus Bader has secured £21.29 million ($25 million) in funding, valuing the brand at £85 million ($1 billion).
The latest investment will support the company’s global growth, focusing particularly on the Asian market and travel retail. Co-founders Dr. Augustinus Bader and Charles Rosier also plan to increase brand awareness via marketing initiatives and continue its US expansion.
This funding was led by historical investor Impala and newcomer General Atlantic, as well as Antoine Arnault, Natalia Vodianova, Diageo Chairman Javier Ferrán, and Mert Alas.
Charles Rosier, CEO of Augustinus Bader, commented: “Reaching unicorn status is a very proud moment for the Augustinus Bader brand. We welcome an investor group of this calibre to our shareholder base as we focus on the strategic expansion of our business.
"We believe there is a significant opportunity to reach more customers globally and look forward to Augustinus Bader’s next phase of growth as we aim to redefine luxury skin and hair care.”
According to sources at WWD, the company's retail sales are expected to be about £170 million ($200 million) this year.
Debuting in 2018 with two wonder products, The Cream and The Rich Cream, Dr. Augustinus Bader launched Trigger Factor Complex (TFC). This patented technology helps skin cells regenerate and it is the foundation of the brand's formulations, amassing over 100 global awards in just four years.
Dr. Augustinus Bader’s TFC8 technology is backed by over 30 years of research. It is composed of natural amino acids, high-grade vitamins and synthesised molecules naturally found in skin, which nourishes the skin by supporting its potential for renewal.